• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Early brain metastasis of advanced gastric cancer with a pathological complete response to neoadjuvant chemotherapy followed by surgery: A case report and literature review.晚期胃癌新辅助化疗后手术病理完全缓解伴早期脑转移 1 例报告及文献复习
Cancer Biol Ther. 2018;19(10):875-878. doi: 10.1080/15384047.2018.1456600. Epub 2018 Apr 30.
2
[Clinical features and prognosis analysis of 21 gastric cancer patients with pathological complete response after neoadjuvant chemotherapy].21例胃癌患者新辅助化疗后病理完全缓解的临床特征及预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Oct 25;20(10):1168-1173.
3
Histological complete response after neoadjuvant XELOX in advanced gastric carcinoma.晚期胃癌新辅助XELOX治疗后的组织学完全缓解
Hepatogastroenterology. 2013 May;60(123):638-40. doi: 10.5754/hge121131.
4
[Histological complete response in a case of advanced gastric cancer treated by neoadjuvant TS-1 combined with CDDP therapy].[新辅助替吉奥(TS-1)联合顺铂(CDDP)治疗晚期胃癌的组织学完全缓解病例]
Gan To Kagaku Ryoho. 2011 Jan;38(1):101-4.
5
[A Case of Stage IV Gastric Cancer Which Showed Pathological Complete Response after Neo-Adjuvant Chemotherapy].[一例新辅助化疗后出现病理完全缓解的IV期胃癌病例]
Gan To Kagaku Ryoho. 2018 Apr;45(4):667-669.
6
[Two cases of advanced gastric cancer achieved pathological complete response by preoperative chemotherapy with S-1 plus weekly low-dose CDDP].两例晚期胃癌经S-1联合每周低剂量顺铂术前化疗实现病理完全缓解
Gan To Kagaku Ryoho. 2014 Nov;41(12):2279-81.
7
[A case of advanced gastric cancer responding to paclitaxel/CDDP neoadjuvant chemotherapy leading to pathologically complete response].
Gan To Kagaku Ryoho. 2008 Aug;35(8):1383-6.
8
Neoadjuvant chemotherapy in controlling lymph node metastasis for locally advanced gastric cancer in a Chinese population.新辅助化疗对中国人群局部晚期胃癌淋巴结转移的控制作用
J Chemother. 2016;28(1):59-64. doi: 10.1179/1973947815Y.0000000028.
9
Neoadjuvant chemotherapy combining docetaxel, cisplatin and S-1 in gastric cancer with para-aortic lymph node metastases: report of five cases.多西他赛、顺铂和S-1联合新辅助化疗治疗伴有腹主动脉旁淋巴结转移的胃癌:5例报告
Hepatogastroenterology. 2010 Nov-Dec;57(104):1650-4.
10
Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis.D2 胃切除术在伴有临床腹腔动脉旁淋巴结转移的胃癌中的作用。
World J Gastroenterol. 2019 May 21;25(19):2338-2353. doi: 10.3748/wjg.v25.i19.2338.

引用本文的文献

1
Case Report: Dramatic response to entritinib in a patient with gastrointestinal stromal tumor positive for fusion.病例报告:一名融合基因阳性的胃肠道间质瘤患者对恩曲替尼产生显著反应。
Front Oncol. 2025 Aug 18;15:1588950. doi: 10.3389/fonc.2025.1588950. eCollection 2025.
2
The Role of Neoadjuvant Therapy in a Giant Gastric Gastrointestinal Stromal Tumour: A Case Report and Review of the Literature.新辅助治疗在巨大胃胃肠道间质瘤中的作用:一例病例报告及文献综述
Cureus. 2024 Mar 6;16(3):e55655. doi: 10.7759/cureus.55655. eCollection 2024 Mar.
3
Brain metastasis from gastric adenocarcinoma: A large comprehensive population-based cohort study on risk factors and prognosis.胃腺癌脑转移:一项基于大规模综合人群队列的危险因素及预后研究
Front Oncol. 2022 Oct 18;12:897681. doi: 10.3389/fonc.2022.897681. eCollection 2022.

本文引用的文献

1
Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.胃癌临床实践指南(NCCN 肿瘤学版) 2016 年第 3 版
J Natl Compr Canc Netw. 2016 Oct;14(10):1286-1312. doi: 10.6004/jnccn.2016.0137.
2
[Survival analysis of gastric cancer cases with pathological complete response received neoadjuvant chemotherapy].接受新辅助化疗后达到病理完全缓解的胃癌病例的生存分析
Zhonghua Yi Xue Za Zhi. 2016 May 31;96(20):1582-4. doi: 10.3760/cma.j.issn.0376-2491.2016.20.008.
3
A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer.一项关于改良FOLFOX6方案作为局部晚期胃癌新辅助化疗的II期研究。
Br J Cancer. 2016 Jun 14;114(12):1326-33. doi: 10.1038/bjc.2016.126. Epub 2016 May 12.
4
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
5
Long-term survival after resection of brain metastases from esophagogastric junction adenocarcinoma: report of two cases and review of the literature.食管胃交界腺癌脑转移瘤切除术后的长期生存:两例报告并文献复习
Clin J Gastroenterol. 2014 Jun;7(3):213-8. doi: 10.1007/s12328-014-0491-5. Epub 2014 May 13.
6
Early gastric cancer with suspected brain metastasis arising eight years after curative resection: a case report.根治性切除术后八年出现疑似脑转移的早期胃癌:一例报告
BMC Res Notes. 2014 Nov 19;7:818. doi: 10.1186/1756-0500-7-818.
7
Long-term survival outcomes of advanced gastric cancer patients who achieved a pathological complete response with neoadjuvant chemotherapy: a systematic review of the literature.新辅助化疗后达到病理完全缓解的晚期胃癌患者的长期生存结局:文献系统综述
Ann Surg Oncol. 2015 Mar;22(3):787-92. doi: 10.1245/s10434-014-4084-9. Epub 2014 Sep 16.
8
Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer.可切除胃食管交界癌中术前剂量强化每周顺铂、表柔比星和紫杉醇(PET)的疗效和可行性的 II 期多中心研究。
Cancer Chemother Pharmacol. 2014 Jul;74(1):141-50. doi: 10.1007/s00280-014-2482-0. Epub 2014 May 14.
9
A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis.XELOX 新辅助化疗联合手术治疗伴有腹主动脉旁淋巴结转移的进展期胃癌患者的 II 期临床试验。
Cancer Chemother Pharmacol. 2014 Jun;73(6):1155-61. doi: 10.1007/s00280-014-2449-1. Epub 2014 Apr 21.
10
Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study.新辅助化疗后局部进展期胃癌CT分期的准确性:一项随机II期研究中的队列评估
Ann Surg Oncol. 2014 Jun;21 Suppl 3:S385-9. doi: 10.1245/s10434-014-3615-8. Epub 2014 Mar 5.

晚期胃癌新辅助化疗后手术病理完全缓解伴早期脑转移 1 例报告及文献复习

Early brain metastasis of advanced gastric cancer with a pathological complete response to neoadjuvant chemotherapy followed by surgery: A case report and literature review.

机构信息

a Division of Graduate, The second clinical medical school and the second affiliated hospital of Zhengzhou University , Zhengzhou , China.

c Department of Radiation Oncology , The affiliated cancer hospital of Zhengzhou University , Zhengzhou , China.

出版信息

Cancer Biol Ther. 2018;19(10):875-878. doi: 10.1080/15384047.2018.1456600. Epub 2018 Apr 30.

DOI:10.1080/15384047.2018.1456600
PMID:29580147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6300339/
Abstract

Advanced gastric cancer with a pathological complete response to neoadjuvant chemotherapy and surgery followed by early brain metastasis is rare. A 52-y-old male patient who was diagnosed with advanced gastric cancer (cT4N2M0, stage ШB). Radiological examinations after three cycles of preoperative chemotherapy with a modified FOLFOX6 (mFOLFOX6) regimen showed a partial response (PR) had been achieved. The patient underwent curative surgery consisting of proximal gastrectomy, and D2 lymph node dissection. The lack of abnormal gastric cancer cells in the primary lesion or lymph nodes confirmed a pathological complete response (pCR). Postoperative chemotherapy with oral S-1 was administrated. However, during the second cycles of postoperative chemotherapy, the patient experienced headaches, projectile vomiting and convulsion. Upon further examination, a tumor representing metastasis to the brain was recognized by cranial enhanced magnetic resonance imaging (MRI) examination and cytopathology of cerebrospinal fluid. In addition to documenting the case report, we reviewed the literature associated to features of metastatic brain malignancies that form from gastric cancer. In short, advanced gastric cancer patents achieved pCR after preoperative chemotherapy typically have good prognosis; however, great attention should be paid on detecting metastatic events.

摘要

新辅助化疗和手术治疗后病理完全缓解,继而早期发生脑转移的进展期胃癌罕见。一名 52 岁男性患者,诊断为进展期胃癌(cT4N2M0,ШB 期)。接受改良 FOLFOX6(mFOLFOX6)方案三周期术前化疗后影像学检查显示部分缓解(PR)。行根治性手术,近端胃切除术和 D2 淋巴结清扫术。原发灶和淋巴结均未见异常胃癌细胞,证实病理完全缓解(pCR)。术后给予 S-1 口服化疗。然而,在第二周期术后化疗时,患者出现头痛、喷射性呕吐和抽搐。进一步检查发现,头颅增强磁共振成像(MRI)检查和脑脊液细胞学证实有脑转移瘤。除了记录病例报告外,我们还回顾了与胃癌形成的转移性脑恶性肿瘤特征相关的文献。简而言之,新辅助化疗后达到 pCR 的进展期胃癌患者通常预后良好,但应高度关注转移事件的发生。